BioWorld MedTech

March 2, 2012

Analysts see Staar on the verge of significant top line growth

Analysts at Canaccord Genuity are saying that Staar Surgical (Monrovia, California) could be poised for tremendous growth in the med-tech sector throughout the next few years. Read More

European Congress of Radiology: Abstracts push aside vendors as scientific program expands

Report from Europe: Trinity Biotech reports it will pay $13.1M for Fiomi Diagnostics

Washington roundup: FDA eyes doc label rule for devices; may expand liability

Financings report: Cardiff University spin-out secures 292,000 in funding

Med-Tech Notes: Berg Diagnostics gets CLIA certification

Deals roundup: Alere to acquire eScreen for about $270 million

Med-Tech Notes: Oxford Diagnostic opens Memphis lab

Restructuring roundup: Columbia Labs reports 42% workforce reduction

New ventures: EnTrust establishes a new healthcare properties division

Product Briefs

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for July 7, 2026.

CINP 2026: Prenatal and adolescent stress shape brain vulnerability

BioWorld Science

Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...